LabNow, Inc. is a point-of-care diagnostics company seeking to become the leading provider of point-of-care solutions by improving the quality of healthcare and lowering treatment costs worldwide. The Company, headquartered in Austin, Texas, has licensed lab-on-a-chip sensor technology with the capability to automate complex fluid analysis quickly, easily, and more accurately than current methods. LabNow’s technology represents a convergence of advances in nanochemistry, microfluidics, imaging analysis, and digital fluorescence microscopy.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 09/29/04 | Series A | 14M | Unknown | |
| 11/20/07 | Series B | 20M | Unknown |
People
Senator Bill Bradley (Advisor)
Trevor Neilson (Advisor)
Darron Ash (Board Member)
Magdalene Cook M.D. (Board Member)
Steve Papermaster (Executive Chairman)
Competitors
GlaxoSmithKline:
We have a challenging and inspiring mission: to improve the quality of human life by enabling… See Company Profile »
Predictive Biosciences:
Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a… See Company Profile »
PointCare Technologies:
PointCare Technologies Inc. is a privately held, FDA-registered, ISO-certified medical diagnostics company based in the United… See Company Profile »
NeoDiagnostix:
NeoDiagnostix was founded to develop and provide cancer diagnostic testing services using genetic technologies. The Company… See Company Profile »
Ikonisys:
Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique… See Company Profile »
News
Life sciences briefing: Wednesday, Nov. 21, 2007
November 21, 2007 3:56 pm
Featured companies: Cerus, LabNow, Reliant Pharmaceuticals UPDATED: Expanded items on Reliant Pharmaceuticals and Cerus. GSK acquires Reliant Pharma for $1.65… Continue reading ⟩